MERCK THE FDA AND THE VIOXX RECALL CASE STUDY ANALYSIS

The relaxation of the rule governing the direct-to-consumer DTC advertising in by the U. The COX-2 medication was effective for treatment of arthritis and other pains without users being exposed to stomach damage by naproxen. Wholeheartedly, any legislation by the U. DTC advertisings offer a lot of information such that would require assistance from professionals to be properly evaluated by the consumer in order to make good choices. The protagonists of DTC advertising have often argued that the mode has raised the awareness for and access to important new medications as well as the ability of patients to actively engage their physicians in informed discussions about their prescription drugs. We use cookies to give you the best experience possible.

A limited time offer! Literature Review Dissertation chapter: Related Essays Pharmaceutical Industry and E. The COX-2 medication was effective for treatment of arthritis and other pains without users being exposed to stomach damage by naproxen. By August, when an FDA researcher presented a comprehensive analysis of data collected over 1. This was the case particularly in the aggressive marketing of Vioxx which evidently was discovered to be dangerous to the consumers but which the company ignored as will be expatiated later in this paper.

DTC advertising could also adversely affect the relationship between the doctor and the patient Beauchamp et al, The Ethical Considerations Clearly, the objective to regain and maintain leadership position in the pharmaceutical industry was paramount to Merck than getting a safe product to the market.

merck the fda and the vioxx recall case study analysis

The quest for make bigger profits and control the painkiller drug market seem to becloud their sense of judgments. Food and Thr Administration FDA paved the way for intensification of such mode of advertising by the pharmaceutical companies. The antagonists argue further that the huge amount of money that pharmaceutical companies expend on DTC advertising could make prescription drugs more expensive to the consumers.

That is why physicians and researchers should be made to disclose their pecuniary interest in any pharmaceutical company and in its drugs. Conclusion The case of Merck and its Vioxx recall has proved that pharmaceutical manufacturing companies need to strongly take into consideration the overall interest of ths good. Merck, looking for ways to entrench its market leadership threatened by impending loss of patent, relied heavily on Vioxx to capture the painkiller drug tthe with which it hoped to shore up its profile and revenue.

  DISSERTATION AYSE KARABABA

These include the competitiveness of very high magnitude that existed in the pharmaceutical industry in the s and the dilemma that Merck faced as a result of a number of its patents that were due to expire.

Case Study: Merck & Company: the Vioxx Recall

Next to this was the approval of Vioxx for marketing to the public by FDA. We use cookies to give you the best experience possible. DTC advertisings offer a lot of information such that would require assistance from professionals to be properly evaluated by the consumer in order to make good choices.

Related Essays Pharmaceutical Industry and E. Retrieved May 22,from https: Retrieved June 9, from http: Congress to ban direct-to-consumer DTC is supported by this author.

Many lives were exposed to the risks of heart attack and strokes when the warning signs were staring them in the face. American Journal of Public Health Vol.

merck the fda and the vioxx recall case study analysis

The possibility that the knowledge gap would exist is very high especially among the less privileged members of the society. With declining fortune, Merck found DTC irresistible and relied on it heavily to shore up its market share and to remain competitive.

Pearson Prentice Hall Green, R.

It appears that the arguments against direct-to-consumer far outweigh arguments for. The COX-2 medication was effective for treatment of arthritis and other pains without users being exposed to stomach damage by naproxen.

At introduction stage, both Merck and FDA acted unethically by speeding up the review process.

  KUMULATIVE DISSERTATION UNI WIEN

Case Study: Merck & Company: the Vioxx Recall | Free Essays –

Upper Saddle River, NJ: During this period, it was discovered by some researchers that COX-2 inhibitors such as Vioxx would interfere with enzymes that very likely to prevent cardiovascular disease. To give effect and credibility to the study, it was controlled and it compared Vioxx with a placebo rather than another drug.

This was the case particularly in the aggressive marketing of Vioxx which evidently was discovered to be dangerous to the consumers but which the company ignored as will be expatiated later in this paper. This case obviously calls for more and stricter regulations by strengthening the operations of FDA. Home Essays Case Study: This gap is therefore open to manipulation to the advantage of the marketer.

merck the fda and the vioxx recall case study analysis

Vioxx and Other Pharmaceutical Product Withdrawals. Ethical Theory and Business.

COX-2 inhibitors are the newest form of nonsteroidal anti-inflammatory drugs NSAIDs and Vioxx, as one of them, was developed to overcome the stomach irritation and gastric bleeding associated with older NSAIDs with COX-1 and Cox-2 inhibitors, which include aspirin, ibuprofen, and naproxen to treat people who are in need of long-term pain relief. The relaxed rule led to widespread use of television to advertise prescription drugs with commensurate big spending by the drug companies Beauchamp et al, The outcome was that even though Vioxx patients showed less stomach damage, there is more blood clot problems than drugs in the naproxen group with five times higher risk of heart attack.

Wholeheartedly, any legislation by the U.

Author: admin